MannKind Corporation
News
Research Analysts Issue Forecasts for MannKind Co.'s Q3 2024 Earnings (NASDAQ:MNKD)
Ticker Report MannKind Co. (NASDAQ:MNKD - Free Report) - Leerink Partnrs issued their Q3 2024 earnings estimates for MannKind in a report issued on Monday, September 9th. Leerink Partnrs analyst F. Khurshid...\n more…
MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare Conference
Globe Newswire DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled...\n more…
Brokers Set Expectations for MannKind Co.'s Q1 2025 Earnings (NASDAQ:MNKD)
Ticker Report MannKind Co. (NASDAQ:MNKD - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for MannKind in a research report issued on Monday, September 9th. Leerink Partnrs...\n more…
MannKind (NASDAQ:MNKD) Upgraded to "Strong-Buy" at Leerink Partnrs
Ticker Report Leerink Partnrs upgraded shares of MannKind (NASDAQ:MNKD - Free Report) to a strong-buy rating in a research report sent to investors on Monday morning, Zacks.com reports. Leerink Partnrs also issued...\n more…
MannKind (NASDAQ:MNKD) Now Covered by Leerink Partners
Ticker Report Leerink Partners started coverage on shares of MannKind (NASDAQ:MNKD - Free Report) in a research note published on Monday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a...\n more…